Page last updated: 2024-09-04

resiquimod and Glioma

resiquimod has been researched along with Glioma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bogdahn, U; Chirasani, SR; Gottfried, E; Grauer, OM; Gronwald, W; Hau, P; Hochrein, J; Kreutz, M; Leukel, P; Neumann, B; Oefner, PJ; Stadler, K1

Other Studies

1 other study(ies) available for resiquimod and Glioma

ArticleYear
Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model.
    International journal of cancer, 2013, Feb-15, Volume: 132, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Cells; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dendritic Cells; Diclofenac; Disease Models, Animal; Female; Glioma; Imidazoles; Immune Tolerance; Interferon-gamma; Interleukin-10; Interleukin-12; Interleukin-2 Receptor alpha Subunit; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lactic Acid; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Phosphorylation; T-Lymphocytes, Regulatory; Transcriptional Activation; Up-Regulation

2013